Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension
This study is currently recruiting participants.
Verified April 2012
by Lee's Pharmaceutical Limited
Study NCT01520285 Information provided by Lee's Pharmaceutical Limited
First Received on January 13, 2012. Last Updated on April 26, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Zanidip
Felodipine sustained-release tablet
Additional drug interventions recognized in this trial
Felodipine
Lercanidipine
More general drug interventions related to this trial
Anti-Arrhythmia Agents
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Lee's Pharmaceutical Limited
Back to top of Main Content